pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 17·1 min read
save

Kennedy appoints eight specialists to U.S. Preventive Services Task Force, ending year-long vacancy

Sep 17, 2026·read at STAT ↗Neutral

Health secretary Robert F. Kennedy Jr. appointed eight new members to the U.S. Preventive Services Task Force, filling vacancies after the panel had not met for more than a year.

The appointees include specialists in clinical nutrition, gastroenterology and oncology, as well as a finance professor with expertise in health insurance, a notable shift from the panel’s traditional generalist makeup.

The broader expertise may shape future assessments of preventive services and could affect insurance coverage decisions for such interventions.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Kennedy moves to revive preventive services panel with new members, after months of vacancies”

read at STAT ↗
637 words · retrieved Sep 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2
topics
Oncology5Cardiology3Approval2Endocrinology & Metabolism2Gastroenterology2Breast CancerHematologyVaccine

related stories

  • 1d agoImmutep, Molecular cut workforcesBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • Sep 10Andy Plump, architect of Takeda’s R&D overhaul, to retire next yearBioPharma Dive
  • Sep 4FDA Grants Accelerated Approval to a New Breast Cancer Treatmentfda press